Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study
This analysis confirmed the overall efficacy and safety of rezafungin demonstrated in ReSTORE, with early efficacy related to front-loaded exposure.
Authors
- Patrick M. Honoré (ORCID: https://orcid.org/0000-0002-6697-4890)
- Yunsong Yu (ORCID: https://orcid.org/0000-0003-2903-918X)
- Àlex Soriano (ORCID: https://orcid.org/0000-0002-9374-0811)
- Sizhou Feng (ORCID: https://orcid.org/0000-0003-2768-6690)
- Marin Kollef
- Matteo Bassetti (ORCID: https://orcid.org/0000-0002-0145-9740)
- Haihui Huang (ORCID: https://orcid.org/0000-0002-6546-969X)
- George R. Thompson (ORCID: https://orcid.org/0000-0001-8518-5750)
- Oliver A. Cornely (ORCID: https://orcid.org/0000-0001-9599-3137)
- Laura A. Cox (ORCID: https://orcid.org/0000-0002-8836-3783)
- Bart Jan Kullberg (ORCID: https://orcid.org/0000-0002-6813-8167)
- José A. Vázquez (ORCID: https://orcid.org/0000-0001-5774-819X)
- Peter G. Pappas (ORCID: https://orcid.org/0000-0003-3643-9931)
Institutions
- Radboud University Nijmegen (NL)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Washington University in St. Louis (US)
- Fudan University (CN)
- Augusta University (US)
- Sir Run Run Shaw Hospital (CN)
- Radboud University Medical Center (NL)
- University of Alabama at Birmingham (US)
- Augusta University Health (US)
- CHU Dinant Godinne UCL Namur (BE)
- Radboud Institute for Molecular Life Sciences (NL)
- Hospital Clínic de Barcelona (ES)
- Mundipharma (United Kingdom) (GB)
- Ospedale Policlinico San Martino (IT)
- Institute of Hematology & Blood Diseases Hospital (CN)
- University Hospital Cologne (DE)
- Huashan Hospital (CN)
- University of California Davis Medical Center (US)
- Zhejiang University (CN)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ofid/ofaf555
- Citations
- 2
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.79